InMode (INMD) Competitors

InMode (NASDAQ:INMD) and PROCEPT BioRobotics (NASDAQ:PRCT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Does the MarketBeat Community prefer INMD or PRCT?

InMode received 121 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. Likewise, 71.18% of users gave InMode an outperform vote while only 68.85% of users gave PROCEPT BioRobotics an outperform vote.

Company	Underperform	Outperform
InMode	Outperform Votes 163 71.18%	Underperform Votes 66 28.82%
PROCEPT BioRobotics	Outperform Votes 42 68.85%	Underperform Votes 19 31.15%

Do analysts rate INMD or PRCT?

InMode currently has a consensus target price of $18.54, suggesting a potential upside of 27.35%. PROCEPT BioRobotics has a consensus target price of $90.00, suggesting a potential upside of 40.12%. Given PROCEPT BioRobotics' stronger consensus rating and higher probable upside, analysts clearly believe PROCEPT BioRobotics is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	0 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.13
PROCEPT BioRobotics	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.86

Do insiders and institutionals hold more shares of INMD or PRCT?

68.0% of InMode shares are owned by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 6.6% of PROCEPT BioRobotics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the media prefer INMD or PRCT?

In the previous week, PROCEPT BioRobotics had 4 more articles in the media than InMode. MarketBeat recorded 7 mentions for PROCEPT BioRobotics and 3 mentions for InMode. InMode's average media sentiment score of 1.79 beat PROCEPT BioRobotics' score of 0.21 indicating that InMode is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
PROCEPT BioRobotics	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is INMD or PRCT more profitable?

InMode has a net margin of 45.91% compared to PROCEPT BioRobotics' net margin of -50.07%. InMode's return on equity of 18.25% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	45.91%	18.25%	16.33%
PROCEPT BioRobotics	-50.07%	-38.57%	-26.06%

Which has more risk & volatility, INMD or PRCT?

InMode has a beta of 1.98, suggesting that its share price is 98% more volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.

Which has better earnings and valuation, INMD or PRCT?

InMode has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$392.41M	2.35	$181.27M	$2.33	6.25
PROCEPT BioRobotics	$249.12M	14.27	-$105.90M	-$1.70	-37.78

Summary

InMode beats PROCEPT BioRobotics on 12 of the 18 factors compared between the two stocks.